| Literature DB >> 31861889 |
Ján Košuth1, Martina Farkašovská1, Filip Mochnacký1, Zuzana Daxnerová1, Juraj Ševc1.
Abstract
In order to obtain unbiased results of target gene expression, selection of the most appropriate reference gene (RG) remains a key precondition. However, an experimental study focused on the validation of stably expressed RGs in the rat spinal cord (SC) during development or after spinal cord injury (SCI) is missing. In our study, we tested the stability of the expression of nine selected RGs in rat SC tissue during normal development (postnatal days 1-43, adulthood) and after minimal (mSCI) and contusion (cSCI) spinal cord injury. The following RGs were tested: common housekeeping genes of basal cell metabolism (Gapdh, Hprt1, Mapk6) and protein translation (Rpl29, Eef1a1, Eif2b2), as well as newly designed RGs (Gpatch1, Gorasp1, Cds2) selected according to the RefGenes tool of GeneVestigator. The stability of RGs was assessed by geNorm, NormFinder, and BestKeeper. All three applets favored Gapdh and Eef1a1 as the most stable genes in SC during development. In both models of SCI, Eif2b2 displayed the highest stability of expression, followed by Gapdh and Gorasp1/Hprt1 in cSCI, and Gapdh and Eef1a1 in the mSCI experiments. To verify our results, selected RGs were employed for normalization of the expression of genes with a clear biological context in the SC-Gfap and Slc1a3/Glast during postnatal development and Aif1/Iba1 and Cd68/Ed1 after SCI.Entities:
Keywords: RT-qPCR; normalization; postnatal development; reference gene; spinal cord; spinal cord injury
Year: 2019 PMID: 31861889 PMCID: PMC7017034 DOI: 10.3390/brainsci10010006
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Candidate reference genes analyzed in the study.
| Gene Symbol | Gene Name | Main Function |
|---|---|---|
|
| CDP-diacylglycerol synthase 2 | Glycerophospholipid metabolism and phosphatidylinositol signaling system |
|
| eukaryotic translation elongation factor 1 alpha 1 | Protein synthesis |
|
| eukaryotic translation initiation factor 2B subunit beta | Protein synthesis |
|
| glyceraldehyde-3-phosphate dehydrogenase | Glycolysis |
|
| golgi reassembly stacking protein 1 | Golgi apparatus structure. |
|
| G patch domain containing 1 | Nucleic acid-binding protein |
|
| hypoxanthine phosphoribosyltransferase 1 | Metabolic salvage of purines |
|
| mitogen-activated protein kinase 6 | Protein kinase |
|
| ribosomal protein L29 | Component of ribosomes (60S subunit) |
Nucleotide sequences of the primers used in RT-qPCR.
| Gene Symbol | Acc. No | Sequence for | Sequence Rev | Length (bp) |
|---|---|---|---|---|
| Reference Genes | ||||
|
| NM_053643 | TGGCTGGAAAACCATGAGGAT | GGTACTGGCAGTCAAAGCGA | 185 |
|
| NM_175838 | TGCTGGAGCCAAGTGCTAAT | GTGCCAATGCCGCCAATTTT | 181 |
|
| NM_032058 | ATCCGCAGAGAGGGTAGGAG | GTGCCTTCCAGTTCCACTAGC | 260 |
|
| NM_017008 | AGACAGCCGCATCTTCTTGT | TGATGGCAACAATGTCCACT | 142 |
|
| NM_019385 | CTGAAGGCTAATGTGGAGAAG | CCAACAATGTAGTCTGTGTAAGG | 239 |
|
| NM_001106246 | GGACCAGCCATCTTCTTGGA | TCTCTCTCGGGTTCTTTGTGA | 226 |
|
| NM_012583 | TGCTGGTGAAAAGGACCTCTC | AGATTCAACTTGCCGCTGTCT | 192 |
|
| NM_031622 | TAAAGCCATTGACATGTGGG | TCGTGCACAACAGGGATAGA | 129 |
|
| NM_017150 | AGTCCAAGAACCACACCACA | ATTCGTATCTTTGTGACCGGGG | 84 |
| Target Genes | ||||
|
| NM_017196 | CCTCATCGTCATCTCCCCAC | CTCCATGTACTTCGTCTTGAAGG | 214 |
|
| NM_001031638 | TGGTTCCCAGCCATGTGTTC | TCTGATGTCGGTCCTGTTTG | 209 |
|
| NM_017009 | CACTCAGTACGAGGCAGTGG | ACTCAAGGTCGCAGGTCAAG | 176 |
|
| NM_019225 | GACCTCCTCAAGTTCTGCCA | ATCTGGTGATGCGTTTGTCC | 83 |
1 adopted from [24], 2 adopted from [18].
Figure 1The range of gene expression of the tested reference and target genes in the rat spinal cord during postnatal development (a) and after SCI (b). The raw Cq values for each gene are represented in the box-and-whisker plot, (a) n = 24 samples (three biological replicates at P1, P8, P15, P22, P29, P36, P43, and P120+), (b) n = 21 samples (three biological replicates of intact P120+ controls, sham-operated animals, and animals subjected to mSCI and cSCI for both survival times).
Stability of gene expression and ranking of the tested reference genes in the spinal cord during rat postnatal development. The ranking of nine RGs according to stability values and coefficient of correlation calculated by the geNorm, NormFinder, and BestKeeper applets. In NormFinder, the three biological replicates at each timepoint (P1, P8, P15, P22, P29, P36, P43, and P120+) represent an individual experimental group.
| geNorm | NormFinder | BestKeeper | ||||||
|---|---|---|---|---|---|---|---|---|
| Gene Rank | Gene | geNorm M | geNorm V | Gene | S Value | Gene | Coeff of Corr. [r] | Std Dev [±Cq] |
| 1 |
| 0.378 | --- |
| 0.196 |
| 0.935 | 0.57 |
| 2 |
| 0.222 |
| 0.891 | 0.49 | |||
| 3 |
| 0.431 | 0.141 |
| 0.231 |
| 0.889 | 0.58 |
| 4 |
| 0.474 | 0.113 |
| 0.270 |
| 0.789 | 0.36 |
| 5 |
| 0.502 | 0.095 |
| 0.290 |
| 0.767 | 0.56 |
| 6 |
| 0.537 | 0.088 |
| 0.312 |
| 0.703 | 0.65 |
| 7 |
| 0.573 | 0.082 |
| 0.355 |
| 0.669 | 0.33 |
| 8 |
| 0.610 | 0.079 |
| 0.400 |
| 0.646 | 0.58 |
| 9 |
| 0.643 | 0.073 |
| 0.407 |
| 0.590 | 0.49 |
Figure 2Relative gene expression of Glast (a) and Gfap (b) in the spinal cord during rat postnatal development. Normalized relative gene expression at P1, P8, P15, P22, P29, P36, P43, and P120+ (adulthood) represents the average of three biological replicates ± standard deviation (SD). The expression of the genes is normalized by the normalization factor based on the expression of Gapdh and Eef1a1.
Stability of gene expression and ranking of the tested reference genes in the rat spinal cord after spinal cord injury (cSCI + mSCI). The ranking of nine RGs according to stability values and coefficient of correlation calculated by geNorm, NormFinder, and BestKeeper applets. In NormFinder, each biological replicate (intact control, sham control, mSCI, and cSCI with 1 and 4 days of survival time) represents an individual experimental group.
| geNorm | NormFinder | BestKeeper | ||||||
|---|---|---|---|---|---|---|---|---|
| Gene Rank | Gene | geNorm M | geNorm V | Gene | S Value | Gene | Coeff of Corr. [r] | Std Dev [±Cq] |
| 1 |
| 0.340 | --- |
| 0.199 |
| 0.881 | 0.36 |
| 2 |
| 0.201 |
| 0.879 | 0.38 | |||
| 3 |
| 0.453 | 0.164 |
| 0.313 |
| 0.825 | 0.67 |
| 4 |
| 0.498 | 0.118 |
| 0.313 |
| 0.813 | 0.70 |
| 5 |
| 0.538 | 0.104 |
| 0.319 |
| 0.720 | 0.63 |
| 6 |
| 0.555 | 0.080 |
| 0.352 |
| 0.717 | 0.67 |
| 7 |
| 0.565 | 0.069 |
| 0.379 |
| 0.690 | 0.78 |
| 8 |
| 0.625 | 0.091 |
| 0.421 |
| 0.658 | 0.53 |
| 9 |
| 0.689 | 0.094 |
| 0.457 |
| 0.212 | 0.55 |
Stability of gene expression and ranking of the tested reference genes in the rat spinal cord after minimal spinal cord injury (mSCI). The ranking of nine RGs according to stability values and coefficient of correlation calculated by the geNorm, NormFinder, and BestKeeper applets. In NormFinder, each biological replicate (intact control, sham control, mSCI with 1 and 4 days of survival time) represents an individual experimental group.
| geNorm | NormFinder | BestKeeper | ||||||
|---|---|---|---|---|---|---|---|---|
| Gene Rank | Gene | geNorm M | geNorm V | Gene | S Value | Gene | Coeff of Corr. [r] | Std Dev [±Cq] |
| 1 |
| 0.261 | --- |
| 0.162 |
| 0.951 | 0.81 |
| 2 |
| 0.187 |
| 0.945 | 0.46 | |||
| 3 |
| 0.281 | 0.087 |
| 0.211 |
| 0.916 | 0.52 |
| 4 |
| 0.361 | 0.104 |
| 0.266 |
| 0.915 | 0.80 |
| 5 |
| 0.410 | 0.085 |
| 0.277 |
| 0.888 | 0.37 |
| 6 |
| 0.454 | 0.080 |
| 0.299 |
| 0.845 | 0.59 |
| 7 |
| 0.485 | 0.070 |
| 0.307 |
| 0.844 | 0.67 |
| 8 |
| 0.508 | 0.061 |
| 0.328 |
| 0.821 | 0.49 |
| 9 |
| 0.576 | 0.084 |
| 0.428 |
| 0.151 | 0.40 |
Stability of the gene expression and ranking of the tested reference genes in the rat spinal cord after contusion spinal cord injury (cSCI). The ranking of nine RGs according to stability values and coefficient of correlation calculated by the geNorm, NormFinder, and BestKeeper applets. In NormFinder, each biological replicate (intact control, sham control, cSCI with 1 and 4 days of survival time) represents an individual experimental group.
| geNorm | NormFinder | BestKeeper | ||||||
|---|---|---|---|---|---|---|---|---|
| Gene Rank | Gene | geNorm M | geNorm V | Gene | S Value | Gene | Coeff of Corr. [r] | Std Dev [±Cq] |
| 1 |
| 0.358 | --- |
| 0.202 |
| 0.845 | 0.27 |
| 2 |
| 0.260 |
| 0.838 | 0.78 | |||
| 3 |
| 0.405 | 0.131 |
| 0.268 |
| 0.817 | 0.81 |
| 4 |
| 0.491 | 0.133 |
| 0.334 |
| 0.787 | 0.81 |
| 5 |
| 0.531 | 0.104 |
| 0.358 |
| 0.779 | 0.35 |
| 6 |
| 0.555 | 0.086 |
| 0.373 |
| 0.773 | 0.71 |
| 7 |
| 0.585 | 0.083 |
| 0.475 |
| 0.768 | 0.53 |
| 8 |
| 0.660 | 0.102 |
| 0.484 |
| 0.496 | 0.67 |
| 9 |
| 0.744 | 0.110 |
| 0.494 |
| −0.112 | 0.60 |
Figure 3Relative gene expression of Ed1 (a) and Iba1 (b) in the rat spinal cord after spinal cord injury (mSCI or cSCI). The injury was performed on adult animals and the survival times were +1 and +4 days. Normalized relative gene expression represents an average of three biological replicates ± SD. Expression of the TGs was normalized by a normalization factor based on the expression of Eif2b2, Gapdh, and Gorasp1.
Reference genes validation studies performed in the nervous tissue of the mouse, rat, and human. PNI—peripheral nerve injury, SNI—spared nerve injury, TBI—traumatic brain injury, mESC—mouse embryonic stem cells.
| Experimental Condition | Tissue | Species | Tested Genes | Best Rated RGs | Reference |
|---|---|---|---|---|---|
| development | spinal cord, brain (cerebellum) | mouse, C57BL/6J | [ | ||
| development | brain (somatosensory cortex, visual cortex) | rat, Wistar | [ | ||
| development, in vitro differentiation | brain (neocortex), cell culture—mESC | mouse, C57BL/6 |
| [ | |
| development | brain (different parts) | mouse, CD-1 |
| [ | |
| aging, dietary restriction, glucocorticoid treatment | brain (cortex, hippocampus) | rat, Wistar | [ | ||
| PNI | dorsal root ganglia | rat, Sprague-Dawley | [ | ||
| PNI | sciatic nerve, dorsal root ganglia | rat, Sprague-Dawley | [ | ||
| SNI | spinal cord, dorsal root ganglia | rat, Sprague-Dawley | [ | ||
| neuropathic pain | dorsal root ganglia | rat, Sprague-Dawley | [ | ||
| inflammatory injury | spinal cord | rat, Sprague-Dawley | [ | ||
| TBI | brain | mouse, CD-1 | [ | ||
| TBI | brain (cortex, hippocampus) | rat, Sprague-Dawley | [ | ||
| TBI | brain (hippocampus, parietotemporal cortex) | rat, Sprague-Dawley | [ | ||
| TBI, aging | brain (hemispheres) | mouse, C57BL/6N | [ | ||
| cancer (astrocytoma) | cell culture—astrocytoma | human | [ | ||
| cancer (gliomas) | cell culture—glioma | human | [ | ||
| in vitro (differentiation0 | cell culture—Oligodendrocytes | rat, Wistar | [ | ||
| in vitro (Borna disease virus infection) | cell culture—primary cortical neurons | rat, Sprague-Dawley | [ | ||
| in vitro (treatment with carbon monoxide) | cell culture—cortical astrocytes | mouse, C57BL/6 | [ | ||
| Disease—neurodegenerative diseases | brain (prefrontal cortex, cerebellum) | human | [ | ||
| Disease—epilepsy | brain (neocortex temporal lobe) | human | [ | ||
| Disease—neurodegenerative disorders | CNS (brain, spinal cord) | human |
| [ | |
| Neuroplasticity—morphine addiction | brain (caudate putamen, hippocampus) | mouse, C57BL/6J | [ | ||
| Neuroplasticity—methamphetamine | brain (striatum, substantia nigra) | rat, Sprague-Dawley | [ | ||
| Neuroplasticity—alcoholism, estrogen | brain, hearth | rat, Sprague-Dawley | [ | ||
| autism | brain (prefrontal cortex, hippocampus) | rat, Sprague-Dawley | [ | ||
| testosterone treatment | brain (hypothalamus), kidney | rat, Sprague-Dawley | [ |